ABSTRACT PURPOSE: Systematic reviews are criticized for frequently offering inconsistent evidences and absence of straightforward recommendations. Their value seems to be depreciated when the conclusions are uncertain. To describe an alternative approach of evaluating case series studies in health care when there is absence of clinical trials.
Introduction
Evidence-based medicine (EBM) is defined as the link between good scientific research and clinical practice 1 . One of EBM´s principal is to integrate patient's values and preferences with the current best evidence. In other words, EBM uses existing and available scientific evidence, with good internal and external validity, to apply its results to clinical practice.
Systematic review is a type of study focused on a research question that tries to identify, appraise, and synthesize all the research evidence that is of high quality. However, this type of review is often criticized for frequently offering evidence that is inconsistent, along with there being an absence of straightforward recommendations given 1 . Their value seems to be depreciated when the conclusions are uncertain 2 .
A cross-sectional study evaluated the conclusions of 1.016 Cochrane systematic reviews of randomized controlled trials in terms of their recommendations for clinical practice and research. It was concluded that the majority (47.83%) of the analyzed reviews did not offer enough evidence for clinical practice (i.e., insufficient evidence), and the authors did asked for further research 3 .
In 2011, the authors reanalyzed the reviews to evaluate whether this percentage had significantly decreased, again they found that most of the Cochrane systematic reviews did not provide a consistent conclusion, of which the author´s review recommended additional studies 4 . The authors concluded that we should produce higher-quality primary studies, in mass, with participation from worldwide center's to cover all "insufficient evidence" scenarios for clinical practice seen in systematic reviews 5 .
Many health areas present an absence of evidence from level 1b (randomized controlled trials), according to the classification of levels of evidence from the Centre for Evidence The bibliographic references in relevant review articles were also examined for eligible studies.
Inclusion criteria
The inclusion criteria consisted of: (a) case series studies, Due to the nature of this type of study there is no tool to evaluate the methodological quality as we are dealing with a low level of evidence.
Statistical analysis
The outcome used as an example for this study was clinical efficacy defined as the percentage of tumours treated successfully by the procedure with its respectively 95% confidential intervals (CI). Due to the clear difference amongst the included studies and several uncontrolled variables, we suggested to use a randomeffect model 9 . StatsDirect was the software used to plot the studies into a meta-analysis.
Interpretation of the forest plots Funnel plots were performed by Egger tests to assess the possibility of publication bias as they are useful adjuncts to metaanalyses.
All the proportional meta-analysis of case series studies was performed using the StatsDirect software.
Results

Absence of RCTs on CA compared to RFA for renal cell carcinoma
The results of the search strategy showed that there was no RCT evaluating RFA versus CA for the treatment of renal tumors 9 . Hence, we found 31 case series studies (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) , 11
RFA [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] ) that met all inclusion criteria and were included in the meta-analysis of case series studies.
Pooled results
The pooled proportion of clinical efficacy was 89% [95% confidential interval (CI) 0.83 to 0.94) in cryoablation therapy from 20 [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] studies with a total of 457 cases. There was statistical significance regarding heterogeneity (I² value)=70.6%) (p<0.0001)
showing the inconsistency of clinical and methodological aspects between the studies included in the meta-analysis (Figure 1 ). 
Interpretation of the proportional meta-analysis of case series studies in our example: pooled results
There was no statistically signifi cance difference regarding clinical effi cacy between CA and RFA therapy as their CIs overlapped (Figures 1, 3 and 5 ). 
Discussion
According to the statistical analysis proposed in this paper we can conclude that there was no signifi cant difference between CA and RFA regarding clinical effi cacy as their CIs overlapped ( Figure 5 ).
Our analysis also demonstrates that there is signifi cant heterogeneity in the clinical outcome of cryoablation ( Figure   1 ), which was already expected to occur as we are dealing with case series studies. Reasons for this heterogeneity could be both of outcomes, and duration of follow-up. There were also methodological differences in the handling of withdrawals and losses to follow up. In addition, the funnel plot for the CA series suggests the possibility that publication bias may have occurred given the asymmetry ( Figure 2) . As for the RFA series, there was far less heterogeneity when it came to the clinical efficacy outcome (Figure 3 ). This suggests that the RFA series were far more consistent in patient selection and treatment protocol.
The alternative approach to deal with the absence clinical trials
Overall it is still desirable to describe the existing data, so that 
The next appeal for the Evidence-Based Medicine age
Cochrane's appeal was that it aimed to represent the first step to establishing good evidence for decision making in health care when he said that we need to organize a critical summary, by specialty or subspecialty, adapted periodically, of all relevant randomized controlled trials 42 . However, the next appeal for the Evidence-Based Medicine age, according to El Dib's, is 'A great criticism of the evidence-based medicine age is that we have not produced enough higher-quality primary studies with worldwide centre participation and in accordance with predefined Cochrane's protocols, to supply all those systematic reviews that did not offer enough evidence for clinical practice' 5 . So until high-quality primary studies are been conducting we offer an alternative approach to deal with the absence of clinical trials in the health field, mainly, in those reviews that did not offer enough evidence for clinical practice (i.e., insufficient evidence), and that the authors did asked for further research.
Conclusions
We describe an alternative approach to evaluate case series studies in health care reviews called proportional metaanalysis of case series studies. Although we are leading to a low 
An alternative approach to deal with the absence of clinical trials.
A proportional meta-analysis of case series studies
